These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9589706

  • 21. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment.
    Fidler IJ.
    J Natl Cancer Inst; 2001 Jul 18; 93(14):1040-1. PubMed ID: 11459857
    [No Abstract] [Full Text] [Related]

  • 22. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors.
    Jia MC, Schwartz MA, Sang QA.
    Adv Exp Med Biol; 2000 Jul 18; 476():181-94. PubMed ID: 10949665
    [Abstract] [Full Text] [Related]

  • 23. Angiogenic cytokines in cartilage tumors.
    McGough RL, Lin C, Meitner P, Aswad BI, Terek RM.
    Clin Orthop Relat Res; 2002 Apr 18; (397):62-9. PubMed ID: 11953596
    [Abstract] [Full Text] [Related]

  • 24. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy.
    Funatsu H, Yamashita H, Shimizu E, Kojima R, Hori S.
    Retina; 2001 Apr 18; 21(5):469-77. PubMed ID: 11642376
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
    Umeda N, Ozaki H, Hayashi H, Kondo H, Uchida H, Oshima K.
    Ophthalmic Res; 2002 Apr 18; 34(1):43-7. PubMed ID: 11834884
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Vascular endothelial growth factor, a specific regulator of angiogenesis.
    Ferrara N, Bunting S.
    Curr Opin Nephrol Hypertens; 1996 Jan 18; 5(1):35-44. PubMed ID: 8834160
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun 18; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

  • 31. Incipient angiogenesis.
    Folkman J.
    J Natl Cancer Inst; 2000 Jan 19; 92(2):94-5. PubMed ID: 10639502
    [No Abstract] [Full Text] [Related]

  • 32. On the mechanism(s) of thrombin induced angiogenesis.
    Maragoudakis ME, Tsopanoglou NE.
    Adv Exp Med Biol; 2000 Jan 19; 476():47-55. PubMed ID: 10949654
    [Abstract] [Full Text] [Related]

  • 33. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
    Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E.
    Br J Ophthalmol; 1996 Mar 19; 80(3):241-5. PubMed ID: 8703862
    [Abstract] [Full Text] [Related]

  • 34. Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment.
    Fannon M, Forsten-Williams K, Dowd CJ, Freedman DA, Folkman J, Nugent MA.
    FASEB J; 2003 May 19; 17(8):902-4. PubMed ID: 12626427
    [Abstract] [Full Text] [Related]

  • 35. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.
    Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S.
    Am J Ophthalmol; 2002 Jan 19; 133(1):70-7. PubMed ID: 11755841
    [Abstract] [Full Text] [Related]

  • 36. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
    Miller JW, Adamis AP, Aiello LP.
    Diabetes Metab Rev; 1997 Mar 19; 13(1):37-50. PubMed ID: 9134347
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, De Placido S, Bianco AR, Tortora G.
    Clin Cancer Res; 2001 May 19; 7(5):1459-65. PubMed ID: 11350918
    [Abstract] [Full Text] [Related]

  • 38. Angiogenesis and metastasis.
    Ellis LM, Fidler IJ.
    Eur J Cancer; 1996 Dec 19; 32A(14):2451-60. PubMed ID: 9059333
    [No Abstract] [Full Text] [Related]

  • 39. Clinical significance of the determination of angiogenic factors.
    Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T.
    Eur J Cancer; 1996 Dec 19; 32A(14):2513-9. PubMed ID: 9059341
    [No Abstract] [Full Text] [Related]

  • 40. [Vascular endothelial growth factor in the ocular fluid in diabetic retinopathy and other retinal diseases].
    Dtsch Med Wochenschr; 1995 Jun 02; 120(22):819. PubMed ID: 7781521
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.